基于磁共振弹性成像的NAFLD肝功能失代偿预测模型:多中心队列研究
这项国际多中心队列研究纳入6家医院接受磁共振弹性成像(MRE)的1254例NAFLD患者,随机分为训练集和验证集(各627例),构建并验证了包含年龄、MRE、白蛋白、天冬氨酸氨基转移酶和血小板的预测模型。该模型对3年和5年肝功能失代偿风险具有优良判别能力,训练集c-statistic分别为0.912和0.891,验证集分别为0.871和0.876,且在两个队列中均优于Fibrosis-4(p < 0.05)。
要点
- MRE联合年龄、白蛋白、AST和血小板构建的模型可预测NAFLD患者3年和5年肝功能失代偿风险。
- 训练集3年和5年c-statistic分别为0.912和0.891,验证集分别为0.871和0.876。
- 该模型在两个队列中判别能力均优于Fibrosis-4(p < 0.05)。
核心结论
- 基于MRE的预测模型能准确预测肝功能失代偿,并有助于NAFLD患者的风险分层。
研究设计与样本
- 国际多中心队列研究,纳入6家医院接受MRE的NAFLD患者共1254例,随机分为训练集627例和验证集627例。
主要发现
- 训练集中位(IQR)年龄为61(18)岁,MRE值为3.5(2.5)kPa;验证集中位(IQR)年龄为60(20)岁,MRE值为3.4(2.5)kPa。
- 训练集模型对3年和5年肝功能失代偿风险的c-statistic分别为0.912和0.891。
- 验证集模型对3年和5年肝功能失代偿风险的c-statistic分别为0.871和0.876。
- 模型在两个队列中判别能力均优于Fibrosis-4(p < 0.05)。
关键数值与推荐
- 预测模型包含年龄、MRE、白蛋白、天冬氨酸氨基转移酶和血小板。
- 主要终点为肝功能失代偿,定义为首次发生食管胃静脉曲张出血、腹水或肝性脑病(HE)。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Magnetic resonance elastography (MRE) is an accurate, continuous biomarker of liver fibrosis; however, the optimal combination with clinical factors to predict the risk of incident hepatic decompensation is unknown. Therefore, we aimed to develop and validate an MRE-based prediction model for hepatic decompensation for patients with NAFLD. APPROACH AND RESULTS: This international multicenter cohort study included participants with NAFLD undergoing MRE from 6 hospitals. A total of 1254 participants were randomly assigned as training (n = 627) and validation (n = 627) cohorts. The primary end point was hepatic decompensation, defined as the first occurrence of variceal hemorrhage, ascites, or HE. Covariates associated with hepatic decompensation on Cox-regression were combined with MRE to construct a risk prediction model in the training cohort and then tested in the validation cohort. The median (IQR) age and MRE values were 61 (18) years and 3.5 (2.5) kPa in the training cohort and 60 (20) years and 3.4 (2.5) kPa in the validation cohort, respectively. The MRE-based multivariable model that included age, MRE, albumin, aspartate aminotransferase, and platelets had excellent discrimination for the 3- and 5-year risk of hepatic decompensation (c-statistic 0.912 and 0.891, respectively) in the training cohort. The diagnostic accuracy remained consistent in the validation cohort with a c-statistic of 0.871 and 0.876 for hepatic decompensation at 3 and 5 years, respectively, and was superior to Fibrosis-4 in both cohorts ( p < 0.05). CONCLUSIONS: An MRE-based prediction model allows for accurate prediction of hepatic decompensation and assists in the risk stratification of patients with NAFLD.
引用
- Kim BK, Bergstrom J, Loomba R, et al. Magnetic resonance elastography-based prediction model for hepatic decompensation in NAFLD: A multicenter cohort study. Hepatology. 2023. PMID: 37203233. doi:10.1097/HEP.0000000000000470
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。